ESMO 2014: Tumour evolution and precision medicine - European Medical Journal

ESMO 2014: Tumour evolution and precision medicine

Oncology
At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how understanding the genetic changes in tumour evolution may contribute to the development of more effective management options that are tailored to individual genetic profiles – this is termed ‘precision medicine’.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now